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may be related to the fact that lympho-
cytes are very sensitive to nutritional
status because they do not store gly-
cogen and rely on the import of extra-
cellular glucose for their energy supply
(La Cava and Matarese, 2004). From
an evolutionary perspective, it may
make survival sense to dampen im-
mune responsiveness during periods
of starvation in order to divert more
energy to food gathering.
The new data provide a possible
strategy for expanding regulatory T
cells in vitro that retain suppressive
activity. It will be of great interest to
determine whether such cells can be
used therapeutically in the treatment
of autoimmune diseases. The results
also open up new ways of thinking
about therapies targeting leptin in vivo
for the treatment of inflammatory
and autoimmune diseases. However,
in addition to the effects previously
mentioned, leptin also influences he-
matopoiesis, angiogenesis, bone and
lipid metabolism, insulin secretion,
and the reproductive system. Conse-
quently, in vivo treatments targeting
such a broad-acting molecule present
a high risk of unexpected and undesir-
able side effects, and considerable
caution and more research are war-
ranted. That said, it will be interesting,
for example, to determinewhether lep-
tin might serve as a natural adjuvant
in vaccinations. Used in a localized
rather than systemic manner, leptin
might simultaneously stimulate T
helper 1 (Th1) responses while down-
modulating regulatory T cells to pro-
duce uniquely potent T cell priming
without producing substantial side ef-
fects. It might also be possible in the
future to expand or contract antigen-
specific subsets of regulatory T cells
through the use of bivalent leptin-
receptor agonists or antagonists. An-
other possible strategy to avoid side
effects might be to use siRNA or other
inhibitors to target downstream sig-
nal-transduction pathways in distinct
cell types. Thus, the new findings on
regulatory T cell and leptin biology
reported by De Rosa et al. (2007)
expand the context for discerning
how regulatory T cell homeostasis
might be perturbed in pathogenic re-
sponses and provide insights into
how we might modulate responses
therapeutically.
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Details of how HIV-1 is transmitted across mucosal barriers remain sparse. In this issue of Immunity,
Hladik et al. (2007) describe an organ culture system for imaging HIV-1 interaction with vaginal epi-
thelial T cells and Langerhans cells early after infection.Immunity 26, February 2007 ª2007 Elsevier Inc. 145Travelogue: An (illustrated) lec-
ture about places and experi-
ences encountered in the
course of travel; hence a film,
broadcast, book, etc., about
travel; a travel documentary.
(Oxford English Dictionary
online: http://www.oed.com/)
The female genital tract is the primary
route for heterosexual transmission ofthe human immunodeficiency virus
(HIV1, referred to in the text as HIV).
On the basis of studies with macaques
exposed to simian immunodeficiency
virus (SIV), it is thought that during
male-to-female transmission, virus in
semen, either cell-free or cell-associ-
ated, penetrates the stratified squa-
mous epithelium of the vagina or the
columnar epithelium of the endocervix
to infect cells within or below the epi-thelium (reviewed in Pope and Haase,
[2003]). This is followed by dissemina-
tion of the virus to lymphoid organs,
particularly gut-associated lymphoid
tissues (GALT), within the first few
days after infection (Li et al., 2005).
Despite intensive efforts to uncover
mechanisms by which HIV traverses
the mucosal barriers and establishes
infection, our understanding of this
process remains limited. It is unclear
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and to be productively infected with
the virus, whether there are environ-
mental factors in the reproductive tract
tissues that influence infection, and
whether there are local immune-sys-
tem responses directed at the virus.
An understanding of these processes
is critical for developing prophylactic
microbicides and vaccines.
Some clues as to how HIV interacts
with mucosal cells in the reproductive
tract may come from studies on infec-
tion of GALT early after exposure of
humans and macaques to HIV or SIV,
respectively. Within days after vaginal
exposure to SIV, there is massive viral
replication and loss of CD4+ memory
T cells in the intestinal lamina propria
of macaques (Li et al., 2005). Similarly,
patients who had recently sero-con-
verted were found to have profound
depletion of lamina-propria CD4+ T
cells (Brenchley et al., 2004). More-
over, the intestinal lamina propria
of patients treated successfully with
highly active antiretroviral therapy
(HAART) remained depleted of CD4+
T cells despite recovery of circulating
CD4+ T cells to normal amounts (Gua-
dalupe et al., 2003). There is as yet no
explanation for this remarkable finding,
although it may be due to irreversible
damage incurred by the lamina propria
during acute infection, such that T cells
can no longer home to the intestine, or
to persistence of virus in the face of
HAART, perhaps because of unusual
properties of the cells in the lamina
propria, such as dendritic cells that
can harbor virus in vacuolar compart-
ments. Although the cervicovaginal
mucosa does not have the density of
lymphoid tissues that is found in the
gastrointestinal mucosa, both contain
an abundant number of effector and
memory T cells that are likely to be im-
portant in providing protection from
breaches in the mucosal barrier. In
both tissues, the T cells are in close
contact with numerous mucosal den-
dritic cells (DCs) that are involved in
innate responses to commensal and
pathogenic microorganisms and that
may also have important roles in the
dissemination of HIV and also in host
responses against the virus. In the
murine intestine, DCs are organized
in a dense network and often extend146 Immunity 26, February 2007 ª2007 Eprocesses through epithelial tight
junctions to sample the luminal en-
vironment. Langerhans cells (LCs),
a specialized type of DC found in skin
and vaginal epithelium, may function
similarly within the stratified epithe-
lium, and may thus provide access for
HIV particles to the vaginal epithelium.
Transcytosis or any breach in the epi-
thelial barrier may also allow HIV parti-
cles to cross the epithelial barrier. The
underlying stroma also contains cells
known to interact with HIV, such as
T cells, macrophages, and DCs.
Because it is not feasible to study
acute events after heterosexual trans-
mission of HIV in humans, research in
this important area has relied on the
simianmodel and also on in vitro infec-
tion of organ cultures established with
cervicovaginal tissue from human sur-
gical samples. In the vagina, the layers
of stratified squamous epithelium and
the mucus that they secrete form the
outer component of the mucosa and
a natural obstacle to infection. Analy-
sis of intact human cervical-tissue
organ cultures has shown that HIV
can penetrate the stratified epithelium
and infect memory CD4+ T cells within
several hours, but this process ap-
pears to be relatively inefficient, and
some investigators have raised the
possibility that LCs may have a key
role early in infection. Because lym-
phocytes and LCs exit the epithelium
within hours after establishment of
organ cultures, it has been difficult to
determine whether cells are infected
within the epithelium proper or in the
submucosal stromal tissue.
In this issue of Immunity, Hladik et al.
(2007) describe a modified organ
culture system that allowed for the
separation of the epithelial sheets
from the underlying stroma in human
vaginal explants. This permitted analy-
sis of cells that were infected exclu-
sively within the epithelium, as well as
examination of cells that migrated out
of the epithelium into the culture me-
dium. Most of the intraepithelial T cells
expressed the surface markers CCR5
and CD45RO, denoting a memory
phenotype. The intact epithelial sheets
were exposed to HIV particles, whose
interaction with resident immune cells
was then examined. Through confocal
microscopy to detect fluorescently la-lsevier Inc.beled virions interacting with cells in
the epithelium, approximately half of
the CD4+ T cells were found to have
bound virions at 2 hr after infection. A
majority of these cells had fluorescent
signals on the cytoplasmic side of the
plasma membrane, indicating that in-
fection had occurred. Both binding
and infection of CD4+ T cells were de-
pendent on CD4 and CCR5, the mole-
cules that make up the viral receptor
complex. HIV was also found associ-
ated with LCs at this early time point,
but the virions were localized in a peri-
nuclear intracellular compartment and
replication was undetectable. The up-
take of virus by LCs was only partially
inhibited by antibodies specific for
CD4 and CCR5, both of which are ex-
pressed at the surface of LCs. Inhibi-
tion of HIV binding to C type lectins
by the use of mannan had very little ef-
fect, suggesting that molecules such
as langerin, which are known to inter-
act with glycans on the envelope gly-
coprotein of HIV, do not have a major
or an exclusive role in viral internaliza-
tion. This is consistent with the notion
that HIV uptake into DCs can occur
by multiple means. Virions within LC
intracellular compartments were read-
ily observed by electron microscopy
for up to 3 days after infection. In con-
trast, intact virions were found only at
the plasma membrane in T cells.
The authors did not observe obvious
contact between LCs and CD4+ T cells
that were undergoing infection at 2 hr.
The results therefore suggest that HIV
directly infects T cells within the vagi-
nal epithelium and that this process is
not dependent on LC-mediated viral
uptake or enhancement of infection in
trans. This is an important point in light
of a growing body of literature sug-
gesting that numerous microorgan-
isms are taken up by dendritic cells
and may exploit these specialized
antigen-presenting cells by hiding out
in their intracellular vesicular compart-
ments (van Kooyk and Geijtenbeek,
2003). It has been known for some
time that DCs are relatively resistant
to infection with HIV, yet they potently
enhance infection of CD4+ T lympho-
cytes in trans (Cameron et al., 1992).
The significance of this process has
yet to be demonstrated for HIV infec-
tion in vivo, and the mechanism for
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PreviewsFigure 1. HIV Interactions within Vaginal Mucosa during Primary Infection
The vaginal mucosal tissue includes a multilayered squamous epithelium and intercalated Lang-
erhans cells (LCs) and intraepithelial T cells. Beneath the epithelium, the stroma contains dendritic
cells (DCs), T cells, and macrophages. As described in Hladik et al. (2007), in organ cultures, HIV
infected the intraepithelial CD4+ T cells and was also detected in intracellular compartments of
LCs. Upon emigration from the tissue, LCs and T cells formed complexes carrying HIV in the
interface (left). The fate of the intracellular virions in the perinuclear vesicles of LCs is still unknown.
They could be transmitted to T cells (bottom left), facilitating their infection, or they could be
trapped and not transmitted (bottom center). Dendritic cells in the stroma could be infected by
virus derived from either T cells or LCs (bottom right).this enhancement has been the sub-
ject of considerable debate. Initial
studies showed that virus-particle up-
take by endocytic mechanisms is nec-
essary for DCs to enhance infection of
T cells, and this finding was supported
by subsequent publications suggest-
ing that virus is transmitted from multi-
vesicular bodies in DCs to conjugated
T cells across an ‘‘infectious synapse’’
(McDonald et al., 2003). Consistent
with such an interpretation, fluores-
cently labeled HIV was found to local-
ize preferentially toward the cell-cell
interface in conjugates of T cells and
LCs that had emigrated from vaginal
explants at 60 hr of culture (Hladik
et al., 2007). Thus, HIV that persists in
vacuolar compartments in LCs may
be involved in infecting CD4+ T cells
at later time points after exposure of
the vaginal epithelium (Figure 1). How-
ever, this interpretation has been chal-lenged by a recent finding that only
virions bound to the surface of DCs
are transmitted in trans to activated
T cells, which suggested that viral
particles within DC intracellular com-
partments are not competent to be re-
leased and infect T cells (Cavrois et al.,
2007). If this is correct, then the virions
observed by Hladek et al. in LCs after
infection of vaginal epithelial explants
may represent a dead-end by-product
of infection (Figure 1). Recent studies
have demonstrated that DCs have
mechanisms that control acidification
of endosomal compartments, ensur-
ing that antigen taken up for cross-pre-
sentation to T cells is not degraded
(Savina et al., 2006). The presence of
intact HIV particles within membrane-
delimited compartments may reflect
this unique property of DCs, but addi-
tional studies are warranted to deter-
mine the fate and infectious compe-Immunity 26tence of these virions, particularly
in vivo in infected patients.
The elegant imaging studies of
Hladik et al. highlight the potential im-
portance of memory T cells and LCs
as the first targets of HIV infection in
the human vagina. The observation
by electron microscopy of intracellular
intact virions several days after infec-
tion in emigrated LCs, coupled with
the finding of viral particles in LC:T
cell conjugates, is consistent with the
possibility that LCs catalyze CD4+ T
cell infection and/or promote transport
of infectious particles to draining lym-
phoid organs. It therefore remains
possible that the success of the virus
in establishing a systemic infection de-
pends on its early interaction with vag-
inal epithelial LCs, particularly when
the amount of virus reaching the intra-
epithelial microenvironment is limited.
Continued development of organ cul-
ture systems that closely mimic the in
vivo environment will be essential for
better understanding the earliest steps
in HIV transmission.
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